概 要
本回顾性队列研究包括了年龄在45岁以下被诊断为伴有或不伴有不典型增生的子宫内膜复杂性增生患者, 对孕激素治疗后的临床结局及妊娠结局进行了比较。结果表明, 伴有或不伴有不典型增生的子宫内膜复杂性增生接受孕激素治疗后, 其临床及妊娠结局并没有显著差异。 我们认为对于这些患者, 在短暂的孕激素治疗控制病情后, 尽快施行体外受精—胚胎移植治疗 (IVF) 将有利于改善其妊娠结局。
References
Chen, M., Jin, Y., Li, Y., et al., 2016. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer. Int. J. Gynaecol. Obstet., 132(1):34–38. http://dx.doi.org/10.1016/j.ijgo.2015.06.046
Gadducci, A., Spirito, N., Baroni, E., et al., 2009. The fertilitysparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option. Gynecol. Endocrinol., 25(10):683–691. http://dx.doi.org/10.1080/09513590902733733
Gallos, I.D., Ganesan, R., Gupta, J.K., 2013. Prediction of regression and relapse of endometrial hyperplasia with conservative therapy. Obstet. Gynecol., 121(6):1165–1171. http://dx.doi.org/10.1097/aog.0b013e31828cb563
Horn, L.C., Meinel, A., Handzel, R., et al., 2007. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann. Diagn Pathol., 11(4):297–311. http://dx.doi.org/10.1016/j.anndiagpath.2007.05.002
Inoue, O., Hamatani, T., Susumu, N., et al., 2016. Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod. Biol. Endocrinol., 14:2. http://dx.doi.org/10.1186/s12958-015-0136-7
Kurman, R.J., Kaminski, P.F., Norris, H.J., 1985. The behavior of endometrial hyperplasia: a long-term study of “untreated” hyperplasia in 170 patients. Cancer, 56(2):403–412. http://dx.doi.org/10.1002/1097-0142(19850715)56:2%3 C403::aid-cncr2820560233%3E3.0.co;2-x
Li, C., Bai, Y., Yan, L., et al., 2016. SPAG9 may be a potential prognostic markerof endometrial hyperplasia and grade 1 endometrioid adenocarcinoma treated with progestin. Gynecol. Obstet. Invest., 81(3):267–274. http://dx.doi.org/10.1159/000437015
Orbo, A., Vereide, A., Arnes, M., et al., 2014. Levonorgestrelimpregnated intrauterine device as treatment for endometrial hyperplasia: a national multicenter randomised trial. BJOG, 121(4):477–486. http://dx.doi.org/10.1111/1471-0528.12499
Randall, T.C., Kurman, R.J., 1997. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet. Gynecol., 90(3):434–440. http://dx.doi.org/10.1016/s0029-7844(97)00297-4
Siristatidis, C., Sergentanis, T.N., Kanavidis, P., et al., 2013. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer—a systematic review and meta-analysis. Hum. Reprod. Update, 19(2): 105–123. http://dx.doi.org/10.1093/humupd/dms051
Stubert, J., Gerber, B., 2016. Current issues in the diagnosis and treatment of endometrial carcinoma. Geburtsh. Frauenheilk., 76(2):170–175. http://dx.doi.org/10.1055/s-0035-1558230
Yang, Y.F., Liao, Y.Y., Liu, X.L., et al., 2015. Prognosticfactors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment. Gynecol. Oncol., 139(3):419–423. http://dx.doi.org/10.1016/j.ygyno.2015.10.015
Zhou, R., Yang, Y., Lu, Q., et al., 2015. Prognostic factors of oncological and reproductive outcomes in fertilitysparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients. Gynecol. Oncol., 139(3):424–428. http://dx.doi.org/10.1016/j.ygyno.2015.09.078
Acknowledgements
We thank BioMed Proofreading LLC for revising the manuscript. We thank Prof. Zi-jiang CHEN of Shandong University (Jinan, China) for her kind guidance of the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No. 81571414), the key Research and Development Program of Shandong Province (No. 2015gsf118124), and the Chinese Medical Association of Clinical Medicine Research Special Funds (No. 16020290645), China
Rights and permissions
About this article
Cite this article
Li, M., Song, Jl., Zhao, Y. et al. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization. J. Zhejiang Univ. Sci. B 18, 1022–1025 (2017). https://doi.org/10.1631/jzus.B1600523
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1600523